During the past decade, State Unitary Enterprise Passengeravtotrans conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "State Unitary Enterprise Passengeravtotrans" are "Crohn Disease" (3 trials). Many other conditions were trialed in "State Unitary Enterprise Passengeravtotrans" in a lesser frequency.

Most popular intervention types in "State Unitary Enterprise Passengeravtotrans" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "State Unitary Enterprise Passengeravtotrans" are 3 trials for "All" genders.

Currently, there are NaN active trials in "State Unitary Enterprise Passengeravtotrans". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in State Unitary Enterprise Passengeravtotrans, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in State Unitary Enterprise Passengeravtotrans, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".